After AI express, investors ask on the investor interaction platform: does the company’s US FDA covid-19 testing business mainly rely on the products of Zhishan biology? Can specific orders be announced
Dirui Industrial Co.Ltd(300396) ( Dirui Industrial Co.Ltd(300396) . SZ) said on the investor interaction platform on April 23 that most of the company’s medical inspection products have passed the CE certification of the European Union, some products have passed the FDA certification of the United States, and the glycosylated hemoglobin test of the company’s biochemical analysis instrument has passed the certification of the national glycosylated blood red egg white standardization plan (ngsp) of the United States. Covid-19 testing products sold overseas by the company are mainly agent products. If the company’s order information meets the requirements of laws and regulations on information disclosure, it will perform the obligation of information disclosure in time.
